Revvity, Inc. (R1VT34)
Sao Paulo Exchange · Brazil · prices in BRL · close of 15 Oct 2026
Key indicators
| Last close | BRL 27.75 |
|---|---|
| 52-week range | 14.90 – 27.75 |
| Return, 1 month / 3 months | +34.7% / +38.7% |
| Return, 1 year / 3 years | +69.9% / +42.2% |
| Trend | Uptrend |
| RSI (14) | 98 |
| Volatility (1 year) | 50.5% |
| Worst drawdown (1 year) | -30.2% |
| Average daily value traded | 0.00M BRL |
| Dividend yield | 0.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Revvity is a life sciences and diagnostics company based in the United States. It provides instruments, reagents, assay kits, software and services used by pharmaceutical and biotechnology researchers, clinical laboratories and academic institutions. Its work supports drug discovery, disease research and diagnostic testing, including newborn screening and reproductive health. The company serves customers around the world from its base in Massachusetts.
Revvity, Inc. is represented on the Sao Paulo Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code R1VT34, with its price quoted in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Revvity, Inc. (R1VT34) trades on the Sao Paulo Exchange in Brazil. It last closed at BRL 27.75 on 15 October 2026.
Its price-based Market X-Ray is 60 out of 100 (a fair price profile), ranking 435 of 1,454 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 69.9% and over the last three months it rose 38.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Sao Paulo Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 93 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 44.4% | ||
| From 52-week high | 0.0% | ||
| Momentum | 88 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 38.8% | ||
| 6-month return | 79.0% | ||
| 12-month return, skipping the last month | 26.1% | ||
| Stability (higher is calmer) | 43 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 50.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -30.2% | ||
| Liquidity | 3 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.00M BRL | ||
| Zero-volume days | 96.7% | ||
| Income | 37 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.1% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | +34.7% |
|---|---|
| 1 month | +34.7% |
| 3 months | +38.7% |
| 6 months | +79.0% |
| 1 year | +69.9% |
| 3 years | +42.2% |
| 5 years | – |
Signals
| 50-day / 200-day average | 21.31 / 19.21 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.40 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 16 Jul 2026 | USD 0.0089 |
| 16 Apr 2026 | USD 0.0086 |
| 15 Jan 2026 | USD 0.0091 |
| 16 Oct 2025 | USD 0.0093 |
| 17 Jul 2025 | USD 0.0096 |
| 17 Apr 2025 | USD 0.0103 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Sao Paulo Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.